http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Roongroj Bhidayasiri,Sasivimol Virameteekul,Jong-Min Kim,Pramod Kr. Pal,Sun Ju Chung 대한파킨슨병및이상운동질환학회 2020 Journal Of Movement Disorders Vol.13 No.2
While many infectious disorders are unknown to most neurologists, coronavirus disease 2019 (COVID-19) is very different. Ithas impacted neurologists and other health care workers, not only in our professional lives but also through the fear and panicwithin our own families, colleagues, patients and their families, and even in the wider public. COVID-19 affects all sorts of individuals,but the elderly with underlying chronic conditions are particularly at risk of severe disease, or even death. Parkinson’s disease(PD) shares a common profile as an age-dependent degenerative disorder, frequently associated with comorbidities, particularlycardiovascular diseases, so PD patients will almost certainly fall into the high-risk group. Therefore, the aim of this review isto explore the risk of COVID-19 in PD based on the susceptibility to severe disease, its impact on PD disease severity, potentiallong-term sequelae, and difficulties of PD management during this outbreak, where neurologists face various challenges on howwe can maintain effective care for PD patients without exposing them, or ourselves, to the risk of infection. It is less than sixmonths since the identification of the original COVID-19 case on New Year’s Eve 2019, so it is still too early to fully understandthe natural history of COVID-19 and the evidence on COVID-19-related PD is scant. Though the possibilities presented arespeculative, they are theory-based, and supported by prior evidence from other neurotrophic viruses closely related to severeacute respiratory syndrome coronavirus 2 (SARS-CoV-2). Neurologists should be on high alert and vigilant for potential acuteand chronic complications when encountering PD patients who are suspected of having COVID-19.
Roongroj Bhidayasiri 대한파킨슨병및이상운동질환학회 2023 Journal Of Movement Disorders Vol.16 No.2
Safinamide is a selective, reversible monoamine oxidase B inhibitor with demonstrated efficacy and tolerability in placebo-controlled studies and is clinically useful for patients with motor fluctuations. This study evaluated the efficacy and safety of safinamide as a levodopa adjunct therapy in Asian patients with Parkinson’s disease.
Onanong Phokaewvarangkul,Roongroj Bhidayasiri 대한파킨슨병및이상운동질환학회 2023 Journal Of Movement Disorders Vol.16 No.3
Researchers consider that the beneficial preventive effects of the Medi diet are attributed to possible synergistic effects or benefits associated with the combined nutrients in the Medi diet rather than a single ingredient. However, despite these emerging health benefits, the perception of the term “Mediterranean” may lead people who live outside these regions to believe that the Medi diet is not applicable or adaptable to non-Mediterranean regions due to the unavailability of certain ingredients in their countries, such as olive oil or red wine. Moreover, many people misunderstand that the Medi diet is restricted only to people living in the Mediterranean area, which is also not accurate. Indeed, the adoption of the Medi diet outside the Mediterranean region in clinical trials (i.e., Australia) has been shown to be feasible, with clinical benefits of improving mental health in patients with depression
Umami and Other Taste Perceptions in Patients With Parkinson’s Disease
Priya - Jagota,Roongroj Bhidayasiri 대한파킨슨병및이상운동질환학회 2022 Journal Of Movement Disorders Vol.15 No.2
Studies of taste perceptions in Parkinson’s disease (PD) patients have been controversial, and none of these studies have assessed umami taste. This study aimed to assess umami, along with the other 4 taste functions in PD patients.
Priya - Jagota,Roongroj Bhidayasiri 대한파킨슨병및이상운동질환학회 2022 Journal Of Movement Disorders Vol.15 No.2
This study aims to validate the Thai translation of the Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS).
Historical and More Common Nongenetic Movement Disorders From Asia
Norlinah Mohamed Ibrahim,Priya Jagota,Pramod Kumar Pal,Roongroj Bhidayasiri,Shen-Yang LIM,Yoshikazu Ugawa,Zakiyah Aldaajani,Beomseok Jeon,Shinsuke Fujioka,Jee-Young Lee,Prashanth Lingappa Kukkle,Huifa 대한파킨슨병및이상운동질환학회 2023 Journal Of Movement Disorders Vol.16 No.3
Nongenetic movement disorders are common throughout the world. The movement disorders encountered may vary depending on the prevalence of certain disorders across various geographical regions. In this paper, we review historical and more common nongenetic movement disorders in Asia. The underlying causes of these movement disorders are diverse and include, among others, nutritional deficiencies, toxic and metabolic causes, and cultural Latah syndrome, contributed by geographical, economic, and cultural differences across Asia. The industrial revolution in Japan and Korea has led to diseases related to environmental toxin poisoning, such as Minamata disease and β-fluoroethyl acetate-associated cerebellar degeneration, respectively, while religious dietary restriction in the Indian subcontinent has led to infantile tremor syndrome related to vitamin B12 deficiency. In this review, we identify the salient features and key contributing factors in the development of these disorders.
Denzel Chong Jen-Rei,Lim Thien Thien,Lee Hock Keong,Hoe Wei Leng,Onanong Phokaewvarangkul,Roongroj Bhidayasiri 대한파킨슨병및이상운동질환학회 2021 Journal Of Movement Disorders Vol.14 No.2
Deep brain stimulation (DBS) is performed in patients withParkinson’s disease (PD) whose motor fluctuations and dyskinesiasare difficult to control with PD medications alone.1 However,DBS has complications of its own, with dyskinesia and unwantedinvoluntary movements experienced by some patients.2This case report highlights an unusual presentation of peak-doseballism associated with DBS powered by an implantable pulsegenerator (IPG) that was approaching the end of its battery life.